Key Points 1. In general, the health-related quality of life (QOL) of transplant recipients is impaired before and improves after liver transplantation. 2. Transplant recipients report largest gains in those aspects of QOL most affected by physical health and smaller improvements in areas affected by psychological functioning. 3. No utility-based measures have been used with liver transplant recipients; therefore, the necessary QOL weights for use in cost-effectiveness evaluations of liver transplantation are lacking. 4. Pretransplantation, the percentage of candidates with alcoholic liver disease (ALD) who work is less than that of candidates without ALD. However, there is no difference in rates of employment posttransplantation. 5. No study has described types of wages and benefits associated with jobs before or after transplantation or the extent to which health insurance benefits associated with employment motivate changes in work status. 6. Many studies in this field used nonvalidated heterogeneous instruments to measure QOL and employment, thus limiting the opportunity to combine results across studies and compare outcomes for liver transplant recipients with other patient populations. (Liver Transpl 2001; 7:S119-S123.) C hronic liver disease and its complications are the ninth leading cause of death in the United States. In addition to its effect on mortality, end-stage liver disease has a profoundly negative impact on functional status outcomes. Patients with liver failure experience various degrees of hepatic encephalopathy, with reduced cognitive function as a result of toxic metabolites that are not cleared by the failing liver and cross the blood-brain barrier. 1 Other clinical manifestations of patients with hepatic encephalopathy include lability of affect, atypical emotional responses, depression, and anxiety. 2 Given that this psychological and intellectual deterioration occurs concomitantly with the physical deterioration associated with liver failure, it is not surprising that patients with end-stage liver disease should have significant impairment of quality of life (QOL), often associated with loss of employment.Liver transplantation is widely accepted as treatment for end-stage liver disease. Currently, more than 85% of adult liver transplant recipients survive the first year after transplantation, and 55% survive more than 9 years. 3 As clinical outcomes of liver transplantation improve, outcomes relating to transplant recipients' overall functional status and QOL become increasingly important targets for evaluation. We recently performed a comprehensive meta-analysis of patients' QOL and employment after liver transplantation from 89 studies that reported on 6,306 patients. [4][5][6] We sought to characterize the overall effect of liver transplantation on various aspects of QOL and describe long-term patterns of employment. Since the publication of this work, several important studies have been published on this topic. In this report, we describe primary results of the meta-analysis and di...